The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.60
Bid: 68.60
Ask: 68.80
Change: 0.00 (0.00%)
Spread: 0.20 (0.292%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 68.60
AXB Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notes Allotment Intimation

8 Sep 2021 14:17

RNS Number : 1559L
Axis Bank Limited
08 September 2021
 

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED

STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL

 

AXIS/CO/CS/274/2021-22

 

September 8, 2021

Dear Sir(s),

 

Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the "Listing Regulations")

 

This is with reference to our letter no. AXIS/CO/CS/251/2021-22 dated August 30, 2021, wherein we had informed that the Bank has initiated the process of issuing of the debt instruments in the form of the Additional Tier 1 Notes in foreign currency, subject to market conditions. We also refer to our letter no. AXIS/CO/CS/262/2021-22 dated September 2, 2021, wherein we had informed that the Bank, acting through its GIFT City branch, has completed the pricing of its U.S. dollar denominated Basel III compliant Additional Tier 1 Notes (the "Notes").

 

We are pleased to inform that the Bank has raised USD 600,000,000 through the issue and allotment of USD denominated, unsecured, 4.10% Basel III compliant, Additional Tier 1 Notes (i) to qualified institutional buyers (as defined in Rule 144A under the United States Securities Act of 1933, as amended (the "U.S. Securities Act")) and (ii) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act.

 

The Notes will be listed on Singapore Exchange Limited, International Securities Market, India International Exchange (IFSC) Limited and the NSE IFSC Limited (NSE International Exchange).

 

This is for information of all concerned, in compliance with the applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

 

Thanking you,

 

Yours sincerely,

For Axis Bank Limited

 

 

 

Girish V. Koliyote

Company Secretary

 

DISCLAIMER

 

The Offering Circular ("OC") for the GMTN programme has not been and will not be registered or filed or published as a prospectus or a statement in lieu of a prospectus with the Registrar of Companies ("RoC"), the Securities and Exchange Board of India ("SEBI") or any other statutory or regulatory body of like nature in India in respect of a public offer or information memorandum or other offering material in respect of any private placement of securities under the Companies Act, 2013, as amended, and the rules framed thereunder or any other applicable Indian laws.

 

The OC has not been and will not be reviewed or approved by any regulatory authority in India, including, but not limited to, the SEBI, the RoC, the Reserve Bank of India, or any stock exchange in India. This OC and the Additional Tier 1 Notes ("Notes") are not and should not be construed as an advertisement, invitation, offer or sale of any securities to the public or any person resident in India.

 

The Notes have not been and will not be, offered or sold to any person resident in India.

 

This information relates to an offering of the Notes to be offered and sold (i) to qualified institutional buyers (as defined in Rule 144A under the United States Securities Act of 1933, as amended (the "U.S. Securities Act")) and (ii) outside the United States in offshore transactions in compliance with Regulation S under the U.S. Securities Act. This information is not an offer of securities for sale in the United States. The Notes referred to herein have not been and will not be registered under the U.S. Securities Act or the laws of any state of the United States or elsewhere and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws of the United States. There is no intention to register any portion of any offering in the United States or to conduct a public offering of securities in the United States or in any other jurisdiction. Nothing in this communication shall constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction in which such offer or sale would be unlawful. No money, securities or other consideration is being solicited by this announcement or the information contained herein and, if sent in response to this announcement or the information contained herein, will not be accepted.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEADNPEFLFEFA
Date   Source Headline
25th Apr 20241:41 pmRNSOutcome of Board Meeting
25th Apr 20247:43 amRNSGrant of Stock Options/Units
25th Apr 20247:38 amRNSRe-appointment of Directors
24th Apr 202412:52 pmRNSOutcome of Board Meeting
24th Apr 202412:45 pmRNSFinancial Results
19th Apr 202410:39 amRNSAppointment of Joint Statutory Auditors
18th Apr 20242:39 pmRNSBoard Meeting Intimation
18th Apr 20247:00 amRNSUpdate on Acquisition
10th Apr 20249:49 amRNSPostal Ballot Notice dated April 4, 2024
3rd Apr 202412:09 pmRNSUpdate on Acquisition
14th Mar 20247:00 amRNSChanges in Senior Management
7th Mar 20249:29 amRNSAllotment of Non Convertible Debentures
1st Mar 20245:01 pmRNSIssuance of Non Convertible Debentures
27th Feb 20242:07 pmRNSAppointment of Executive Director
21st Feb 20241:25 pmRNSCredit Rating
14th Feb 202412:39 pmRNSAppointment of Additional Independent Director
24th Jan 202410:53 amRNSRevision in Vesting Period - ESOS
24th Jan 202410:49 amRNSOutcome of Board Meeting - 24012024
23rd Jan 202412:01 pmRNSInvestor Presentation and Press Release
23rd Jan 202411:46 amRNSOutcome of Board Meeting
18th Jan 20242:15 pmRNSCessation
3rd Jan 20243:11 pmRNSBoard Meeting Intimation
15th Dec 20238:36 amRNSCessation
1st Dec 20231:52 pmRNSPostal Ballot Results
22nd Nov 20232:22 pmRNSCredit Rating - ICRA
22nd Nov 20232:22 pmRNSCredit Rating
17th Nov 20237:00 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
1st Nov 20238:36 amRNSPostal Ballot Notice
26th Oct 20232:46 pmRNSPostal Ballot Voting Results
26th Oct 20231:35 pmRNSCessation
26th Oct 202312:56 pmRNSAppointment of Whole Time Director
25th Oct 202312:40 pmRNSRelated Party Transaction
25th Oct 202312:18 pmRNSInvestor Presentation and Press Release
25th Oct 202312:02 pmRNSOutcome of Board Meeting 25102023
17th Oct 202310:00 amRNSCredit Rating
6th Oct 20231:25 pmRNSBoard Meeting Intimation 25102023
3rd Oct 20233:00 pmRNSCredit Rating
3rd Oct 20239:54 amRNSCredit Rating
26th Sep 202312:46 pmRNSPostal Ballot Notice
13th Sep 202310:07 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
18th Aug 202311:17 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
17th Aug 20234:46 pmRNSRBI Approval for appointment of Subrat Mohanty
9th Aug 20231:45 pmRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
9th Aug 202312:36 pmRNSDisclosure Under Reg 30 of SEBI (LODR) Reg, 2015
1st Aug 20234:58 pmRNSResignation of Independent Director
28th Jul 20233:47 pmRNSVoting Results AGM
27th Jul 20231:54 pmRNSOutcome of Board meeting
27th Jul 202310:47 amRNSAppointment
26th Jul 202312:50 pmRNSInvestor Presentation and Press Release
26th Jul 202312:44 pmRNSOutcome of Board Meeting 26072023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.